§ 90-325. 3. No liability to heirs for outstanding debt related to use of investigational drugs, biological products, or devices.
If an eligible patient dies during treatment with an investigational drug, biological product, or device, the patient’s heirs are not liable for treatment-related debt.
AI-assisted research synopsis — verify against the official legal text below.
- Jurisdiction
- United States — North Carolina
- Instrument
- Act or statute
- Version
- Undated source snapshot
- Language
- en
- Official source
- View official record ↗
medical treatment patient estates
Publicly available, excluded from search-engine indexing
This page remains available for direct access and API use, but this release emits
noindex,follow for the following reason:
- The record does not meet this release's canonical indexing criteria.
(market-indexing-disabled)
Statute overview
About this statute
This page preserves the statute’s identified version, provision structure, official source link, and stored legal text for reading and research.
Ask AI about this statute
§ 90-325. 3. No liability to heirs for outstanding debt related to use of investigational drugs, biological products, or devices.
Sign in to ask AI about this statute
Sign in to start authenticated, citation-grounded statute research.
Sign in